More studies are needed in the future to explore the role of Sirtuin 1 in the relationship between GGT/HDL-C ratio and MetS, which may help to reduce the risk of MetS in subjects with T2DM, to start treatment early, and to improve the quality of life of patients. This evidence concerns the gene SIRT1 and metabolic syndrome.